SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-022381
Filing Date
2022-01-31
Accepted
2022-01-31 07:48:03
Documents
14
Period of Report
2022-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d295583d8k.htm   iXBRL 8-K 23868
2 EX-99.1 d295583dex991.htm EX-99.1 12168
6 GRAPHIC g295583snap2.jpg GRAPHIC 3373
  Complete submission text file 0001193125-22-022381.txt   164664

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA biib-20220125.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20220125_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20220125_pre.xml EX-101.PRE 10819
8 EXTRACTED XBRL INSTANCE DOCUMENT d295583d8k_htm.xml XML 3204
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 22571361
SIC: 2836 Biological Products, (No Diagnostic Substances)